Literature DB >> 27976925

Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.

Marleah Dean1, Lindy G Davidson2.   

Abstract

Individuals with a genetic predisposition to develop hereditary breast and ovarian cancer (HBOC), but who have not been diagnosed with cancer, are referred to as previvors. Although genetic testing may reduce previvors' worries about whether or not they have a high genetic cancer risk, testing positive produces negative emotions and long-term uncertainty-thus requiring the management of uncertainty. Existing research indicates family, friends, and social support networks are limited in their assistance for previvors' uncertainty management. Therefore, this study examined how health care providers may assist previvors in uncertainty management by asking: What strategies do BRCA-positive previvors enact with their health care providers to help manage their uncertainty about HBOC? Purposive sampling was employed to recruit participants via online social media. The final sample consisted of 34 BRCA-positive women. Interviews revealed four uncertainty management strategies-seeking health care providers as informational sources, seeking health care providers as partners for decision making, seeking health care providers for supportive communication, and seeking referrals from health care providers for social support networks. Findings indicate that health care providers who are knowledgeable about BRCA, provide information, answer questions, check understanding, and provide additional resources assist previvors in managing their uncertainties by distinguishing options and fostering meaning.

Entities:  

Mesh:

Year:  2016        PMID: 27976925     DOI: 10.1080/10410236.2016.1250187

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  10 in total

1.  Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.

Authors:  Athena Puski; Shelly Hovick; Leigha Senter; Amanda Ewart Toland
Journal:  J Genet Couns       Date:  2018-03-29       Impact factor: 2.537

2.  The Patient-Provider Relationship: Predictors of black/African American Cancer Patients' Perceived Quality of Care and Health Outcomes.

Authors:  Matthew Asare; Christina Fakhoury; Nealey Thompson; Eva Culakova; Amber S Kleckner; Georges Adunlin; Karen Reifenstein; Gabriel A Benavidez; Charles S Kamen
Journal:  Health Commun       Date:  2019-06-05

3.  Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test.

Authors:  Jada G Hamilton; Margaux Genoff Garzon; Ibrahim H Shah; Kechna Cadet; Elyse Shuk; Joy S Westerman; Jennifer L Hay; Kenneth Offit; Mark E Robson
Journal:  Public Health Genomics       Date:  2020-03-19       Impact factor: 2.000

4.  Referencing BRCA in hereditary cancer risk discussions: In search of an anchor in a sea of uncertainty.

Authors:  Margaret Waltz; Anya E R Prince; Julianne M O'Daniel; Ann Katherine M Foreman; Bradford C Powell; Jonathan S Berg
Journal:  J Genet Couns       Date:  2020-01-22       Impact factor: 2.537

5.  Experiencing the cancer of a loved one influences decision-making for breast cancer prevention.

Authors:  Tasleem J Padamsee; Anna Muraveva; Lisa D Yee; Celia E Wills; Electra D Paskett
Journal:  J Health Psychol       Date:  2017-12-15

6.  The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.

Authors:  Hamizah Sa'at; Yew-Kong Lee; Sook-Yee Yoon; Siu Wan Wong; Yin Ling Woo; Kristine Barlow-Stewart; Nur Aishah Mohd Taib
Journal:  Fam Cancer       Date:  2021-02-19       Impact factor: 2.375

7.  Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.

Authors:  Ian Solsky; Jinbo Chen; Timothy R Rebbeck
Journal:  Gynecol Oncol       Date:  2020-01-07       Impact factor: 5.304

8.  A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1/2 gene alteration: "So many little, little traumas could have been avoided".

Authors:  Nikolett Zsuzsanna Warner; AnnMarie Groarke
Journal:  BMC Health Serv Res       Date:  2022-08-06       Impact factor: 2.908

9.  Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study.

Authors:  Hamizah Sa'at; Yew-Kong Lee; Sook-Yee Yoon; Siu Wan Wong; Yin Ling Woo; Kristine Barlow-Stewart; Nur Aishah Mohd Taib
Journal:  Int J Behav Med       Date:  2021-03-31

Review 10.  Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review.

Authors:  Talin Boghosian; Jeanna M McCuaig; Lindsay Carlsson; Kelly A Metcalfe
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.